TLR2 and Parkinson disease: In addition, TLR2 knock-out in a human neuroblastoma cell line and the use of a small molecule TLR2 inhibitor (NPT1220-321) in induced pluripotent stem cell-derived neurons from a patient with PD have both demonstrated that αSyn pathology can be attenuated [158].